Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncotelic Therapeutics Inc (OP: OTLC )

0.0330 +0.0007 (+2.17%)
Streaming Delayed Price Updated: 3:18 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Oncotelic Therapeutics Inc

Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Publishes SITC Meeting 2022 Presentation Materials
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Pediatric Gliomas
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Announces Formation of Animal Health Division
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Oncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual Meeting
From Oncotelic Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.